X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (57) 57
oncology (40) 40
index medicus (33) 33
female (26) 26
male (26) 26
cancer (21) 21
middle aged (21) 21
lung neoplasms - pathology (20) 20
article (18) 18
lung cancer (18) 18
lung neoplasms - genetics (16) 16
aged (15) 15
animals (14) 14
research (13) 13
carcinoma, non-small-cell lung - genetics (12) 12
carcinoma, non-small-cell lung - pathology (12) 12
cell line, tumor (11) 11
lung neoplasms - metabolism (11) 11
risk factors (11) 11
adult (10) 10
breast-cancer (10) 10
care and treatment (10) 10
health aspects (10) 10
lung neoplasms - mortality (10) 10
mutation (10) 10
prevention (10) 10
risk (10) 10
smoking (10) 10
cell biology (9) 9
gene expression regulation, neoplastic (9) 9
lung neoplasms - drug therapy (9) 9
tumors (9) 9
adenocarcinoma - pathology (8) 8
aged, 80 and over (8) 8
carcinoma, squamous cell - genetics (8) 8
genetic aspects (8) 8
lung-cancer (8) 8
mice (8) 8
multidisciplinary sciences (8) 8
prognosis (8) 8
respiratory system (8) 8
squamous-cell carcinoma (8) 8
2nd primary tumors (7) 7
carcinoma (7) 7
carcinoma, non-small-cell lung - metabolism (7) 7
carcinoma, non-small-cell lung - mortality (7) 7
clinical trials as topic (7) 7
respiratory tract diseases (7) 7
activation (6) 6
apoptosis (6) 6
biochemistry & molecular biology (6) 6
carcinogenesis (6) 6
chemoprevention (6) 6
expression (6) 6
genes (6) 6
genetics & heredity (6) 6
identification (6) 6
lung cancer, non-small cell (6) 6
mice, nude (6) 6
mutations (6) 6
neoplasms, second primary - prevention & control (6) 6
polymorphism, single nucleotide (6) 6
treatment outcome (6) 6
adenocarcinoma - genetics (5) 5
bronchial epithelial-cells (5) 5
carcinoma, non-small-cell lung - drug therapy (5) 5
carcinoma, squamous cell - drug therapy (5) 5
carcinoma, squamous cell - pathology (5) 5
chemotherapy (5) 5
development and progression (5) 5
gene expression (5) 5
gene-expression (5) 5
head (5) 5
head and neck neoplasms - drug therapy (5) 5
head and neck neoplasms - prevention & control (5) 5
kaplan-meier estimate (5) 5
proteins (5) 5
research article (5) 5
retinoic acid (5) 5
science (5) 5
smoking - adverse effects (5) 5
survival (5) 5
xenograft model antitumor assays (5) 5
abridged index medicus (4) 4
adenocarcinoma - metabolism (4) 4
adenocarcinoma of lung (4) 4
anticarcinogenic agents - therapeutic use (4) 4
antineoplastic agents - pharmacology (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
articles (4) 4
carcinoma, squamous cell - metabolism (4) 4
diagnosis (4) 4
disease-free survival (4) 4
drug therapy, combination (4) 4
epidemiology (4) 4
erlotinib (4) 4
factor-i receptor (4) 4
gene expression profiling (4) 4
head and neck neoplasms - genetics (4) 4
igf type 1 (4) 4
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Tefferi, Ayalew, MD and Kantarjian, Hagop, MD and Rajkumar, S. Vincent, MD and Baker, Lawrence H., DO and Abkowitz, Jan L., MD and Adamson, John W., MD and Advani, Ranjana Hira, MD and Allison, James, MD and Antman, Karen H., MD and Bast, Robert C., MD and Bennett, John M., MD and Benz, Edward J., MD and Berliner, Nancy, MD and Bertino, Joseph, MD and Bhatia, Ravi, MD and Bhatia, Smita, MD and Bhojwani, Deepa, MD and Blanke, Charles D., MD and Bloomfield, Clara D., MD and Bosserman, Linda, MD and Broxmeyer, Hal E., PhD and Byrd, John C., MD and Cabanillas, Fernando, MD and Canellos, George Peter, MD and Chabner, Bruce A., MD and Chanan-Khan, Asher, MD and Cheson, Bruce, MD and Clarkson, Bayard, MD and Cohn, Susan L., MD and Colon-Otero, Gerardo, MD and Cortes, Jorge, MD and Coutre, Steven, MD and Cristofanilli, Massimo, MD and Curran, Walter J., MD and Daley, George Q., MD, PhD and DeAngelo, Daniel J., MD, PhD and Deeg, H. Joachim, MD and Einhorn, Lawrence H., MD and Erba, Harry P., MD, PhD and Esteva, Francisco J., MD, PhD and Estey, Elihu, MD and Fidler, Isaiah J., DVM, PhD and Foran, James, MD and Forman, Stephen, MD and Freireich, Emil, MD and Fuchs, Charles, MD, MPH and George, James N., MD and Gertz, Morie A., MD and Giralt, Sergio, MD and Golomb, Harvey, MD and Greenberg, Peter, MD and Gutterman, Jordan, MD and Handin, Robert I., MD and Hellman, Samuel, MD and Hoff, Paulo Marcelo, MD and Hoffman, Ronald, MD and Hong, Waun Ki, MD and Horowitz, Mary, MD, MS and Hortobagyi, Gabriel N., MD and Hudis, Clifford, MD and Issa, Jean Pierre, MD and Johnson, Bruce Evan, MD and Kantoff, Philip W., MD and Kaushansky, Kenneth, MD and Khayat, David, MD, PhD and Khuri, Fadlo R., MD and Kipps, Thomas J., MD, PhD and Kripke, Margaret, PhD and Kyle, Robert A., MD and Larson, Richard A., MD and Lawrence, Theodore S., MD, PhD and Levine, Ross, MD and Link, Michael P., MD and Lippman, Scott M., MD and Lonial, Sagar, MD and Lyman, Gary H., MD, MPH and Markman, Maurie, MD and Mendelsohn, John, MD and Meropol, Neal J., MD and Messinger, Yoav, MD and Mulvey, Therese M., MD and O’Brien, Susan, MD and Perez-Soler, Roman, MD and Pollock, Raphael, MD, PhD and Prchal, Josef, MD and Press, Oliver, MD, PhD and Radich, Jerald, MD and Rai, Kanti, MD and Rosenberg, Saul A., MD and Rowe, Jacob M., MD and Rugo, Hope, MD and Runowicz, Carolyn D., MD and Sandmaier, Brenda M., MD and Saven, Alan, MD and Schafer, Andrew I., MD and Schiffer, Charles, MD and Sekeres, Mikkael A., MD, MS and Silver, Richard T., MD and Siu, Lillian L., MD and Steensma, David P., MD and ...
Mayo Clinic Proceedings, ISSN 0025-6196, 2015, Volume 90, Issue 8, pp. 996 - 1000
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2015, Volume 92, Issue 2, pp. 317 - 324
Purpose To test, in a single-arm, prospective, phase 2 trial, whether adding the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor erlotinib to... 
Radiology | Hematology, Oncology and Palliative Medicine | TYROSINE KINASE INHIBITORS | TRIAL | EGFR INHIBITORS | GEFITINIB | ONCOLOGY | EPIDERMAL-GROWTH-FACTOR | PHASE-II | RADIOTHERAPY | FACTOR RECEPTOR | RADIATION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | CONCURRENT CHEMORADIOTHERAPY | Erlotinib Hydrochloride | Receptor, Epidermal Growth Factor - genetics | Adenocarcinoma - pathology | Prospective Studies | Area Under Curve | Lung Neoplasms - mortality | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Feasibility Studies | Brain Neoplasms - secondary | Carcinoma, Non-Small-Cell Lung - secondary | Carcinoma, Squamous Cell - mortality | Time Factors | Aged, 80 and over | Dose Fractionation | Female | Adenocarcinoma - genetics | Paclitaxel - administration & dosage | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Chemoradiotherapy - methods | Drug Administration Schedule | Carcinoma, Non-Small-Cell Lung - genetics | Carboplatin - administration & dosage | Carcinoma, Squamous Cell - therapy | Lung Neoplasms - therapy | Carcinoma, Non-Small-Cell Lung - mortality | Adenocarcinoma - secondary | Disease Progression | Disease-Free Survival | Carcinoma, Non-Small-Cell Lung - therapy | Adenocarcinoma - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Quinazolines - therapeutic use | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Carcinoma, Squamous Cell - secondary | Aged | Mutation | Adenocarcinoma - mortality | Radiotherapy, Intensity-Modulated | Sects | Lung cancer, Small cell | Development and progression | Erlotinib | Lung cancer, Non-small cell | Patient outcomes | Index Medicus | SMOKES | PATIENTS | FAILURES | LUNGS | TOXICITY | CHEMOTHERAPY | GROWTH FACTORS | TYROSINE | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE | MUTATIONS | RECEPTORS | BRAIN | COMBINED THERAPY | NCT00563784 | locally advanced non-small cell lung cancer | tyrosine kinase inhibitor | Tarceva | prospective phase II trial | epidermal growth factor receptor
Journal Article
05/2014, ISBN 1118468740, 634
Jack A. Roth, MD, F.A.C.S., is Professor and Bud Johnson Clinical Distinguished Chair in the Department of Thoracic and Cardiovascular Surgery, Professor of... 
Treatment | Lungs | Diagnosis | Diseases | Cancer
eBook
Journal of Thoracic Oncology, ISSN 1556-0864, 04/2017, Volume 12, Issue 4, pp. 597 - 598
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2016, Volume 11, Issue 7, pp. e0160004 - e0160004
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2010, Volume 5, Issue 2, p. e9112
Background: Non-small cell lung cancer (NSCLC) represents the majority (85%) of lung cancers and is comprised mainly of adenocarcinomas and squamous cell... 
BRANCHING MORPHOGENESIS | STEM-CELLS | ONCOGENE | FIBROBLAST-GROWTH-FACTOR | CANCER | BIOLOGY | Immunohistochemistry | Adenocarcinoma - pathology | Oligonucleotide Array Sequence Analysis | Tissue Array Analysis | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - metabolism | Carcinoma, Squamous Cell - pathology | Homeodomain Proteins - metabolism | Humans | Lung Neoplasms - metabolism | Gene Expression Regulation, Neoplastic | Lung - chemistry | Lung Neoplasms - pathology | Male | Precancerous Conditions - metabolism | Gene Expression Profiling | SOXB1 Transcription Factors - metabolism | Octamer Transcription Factor-3 - genetics | Adenocarcinoma - metabolism | SOXB1 Transcription Factors - genetics | Female | Precancerous Conditions - pathology | Adenocarcinoma - genetics | Lung - metabolism | Cell Lineage - genetics | Lung Neoplasms - genetics | Lung - pathology | Nanog Homeobox Protein | Reverse Transcriptase Polymerase Chain Reaction | Precancerous Conditions - genetics | Homeodomain Proteins - genetics | Octamer Transcription Factor-3 - metabolism | Cluster Analysis | Squamous cell carcinoma | RNA | Genes | Analysis | Genetic aspects | Genetic transcription | Lung cancer, Non-small cell | Embryonic stem cells | Cancer | Cell proliferation | Pathogenesis | Oct-4 protein | Hyperplasia | Lung cancer | Oncology | Data mining | Datasets | Respiratory tract | Morphogenesis | Cell activation | Rodents | Fibroblasts | Lesions | Alveoli | Growth factors | Sox2 protein | Deoxyribonucleic acid--DNA | Dysplasia | Non-small cell lung carcinoma | Lung carcinoma | Gene expression | Esophagus | Pathology | Insects | Biopsy | Data sets | Stem cells | Epigenetics | Tumors | Deoxyribonucleic acid | DNA
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 03/2015, Volume 290, Issue 12, pp. 7345 - 7359
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 05/2011, Volume 103, Issue 10, pp. 817 - 825
Journal Article
PLoS ONE, ISSN 1932-6203, 2010, Volume 5, Issue 8, p. e12402
Treatment of non-small cell lung cancer (NSCLC) with radiotherapy or chemoradiotherapy is often accompanied by the development of esophagitis and pneumonitis.... 
BREAST-CANCER | ALLERGIC INFLAMMATION | TNF POLYMORPHISM | NORMAL TISSUE-REACTIONS | TRANSCRIPTION | BIOLOGY | FUNCTIONAL-ANALYSIS | NITRIC-OXIDE | NECROSIS-FACTOR-ALPHA | 3-DIMENSIONAL CONFORMAL RADIOTHERAPY | SINGLE-NUCLEOTIDE POLYMORPHISMS | Lung Neoplasms - genetics | Carcinoma, Non-Small-Cell Lung - radiotherapy | Genetic Predisposition to Disease | Radiation Pneumonitis - etiology | Carcinoma, Non-Small-Cell Lung - genetics | Humans | Middle Aged | Lung Neoplasms - radiotherapy | Male | Esophagitis - etiology | Radiation Injuries - etiology | Esophagitis - genetics | Radiation Injuries - genetics | Radiation Pneumonitis - genetics | Alleles | Survival Analysis | Inflammation - genetics | Female | Polymorphism, Single Nucleotide | Care and treatment | Pneumonia | Bacterial pneumonia | Genes | Lung cancer, Small cell | Genetic aspects | Inflammation | Single nucleotide polymorphisms | Lung cancer, Non-small cell | Radiotherapy | Transcription factors | Toxicity | Lung cancer | Radiation | Risk | Oncology | Arthritis | Single-nucleotide polymorphism | Epidemiology | Cancer therapies | Rodents | Bowel disease | Interleukin 1 | Tumor necrosis factor-TNF | Interleukin 8 | Genotypes | Lupus | Enzymes | Radiation effects | Non-small cell lung carcinoma | Esophagitis | Genetic diversity | Interleukin 13 | Radiation therapy | Gene expression | Patients | Radiation dosage | Genetic variance | Pneumonitis | Tumor necrosis factor | Biopsy | Nitric oxide | Cyclooxygenase-2 | Variation | Smoking | Cancer | Apoptosis
Journal Article